Ab Investor Net Worth

The estimated Net Worth of Ab Investor is at least $5.3 Million dollars as of 29 May 2014. Ab Investor owns over 2,509,949 units of Agile Therapeutics Inc stock worth over $5,300,023 and over the last 16 years Ab sold AGRX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ab Investor AGRX stock SEC Form 4 insiders trading

Ab has made over 4 trades of the Agile Therapeutics Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently Ab bought 2,509,949 units of AGRX stock worth $15,059,694 on 29 May 2014.

The largest trade Ab's ever made was buying 2,509,949 units of Agile Therapeutics Inc stock on 29 May 2014 worth over $15,059,694. On average, Ab trades about 933,662 units every 502 days since 2008. As of 29 May 2014 Ab still owns at least 3,509,949 units of Agile Therapeutics Inc stock.

You can see the complete history of Ab Investor stock trades at the bottom of the page.

What's Ab Investor's mailing address?

Ab's mailing address filed with the SEC is ARSENALSGATAN 8C S-103, , STOCKHOLM, V7, .

Insiders trading at Agile Therapeutics Inc

Over the last 10 years, insiders at Agile Therapeutics Inc have traded over $2,369,944 worth of Agile Therapeutics Inc stock and bought 24,967,253 units worth $79,522,957 . The most active insiders traders include Advisors Llcperceptive Life..., Ab Investor, and Capital Iii Llc Care Capita.... On average, Agile Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $1,032,678. The most recent stock trade was executed by Alfred Altomari on 26 August 2022, trading 50,000 units of AGRX stock currently worth $22,500.

What does Agile Therapeutics Inc do?

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.

Complete history of Ab Investor stock trades at Agile Therapeutics Inc

Agile Therapeutics Inc executives and stock owners

Agile Therapeutics Inc executives and other stock owners filed with the SEC include:

• Alfred Altomari,
  Chairman of the Board, Chief Executive Officer
• Alfred F. Altomari,
  Chairman & CEO
• Geoffrey Gilmore,
  Senior Vice President, General Counsel, Corporate Secretary
• Geoffrey P. Gilmore,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Dr. Paul Korner M.B.A., M.D.,
  Sr. VP & Chief Medical Officer
• Robert Conway,
  Senior Vice President and Chief Supply Chain Officer
• Dennis P. Reilly,
  Sr. VP & CFO
• John Hubbard,
  Independent Director
• James Tursi,
  Independent Director
• Seth Fischer,
  Lead Independent Director
• Ajit Shetty,
  Independent Director
• Sharon Barbari,
  Independent Director
• Sandra Carson,
  Director
• Paul Korner,
  Chief Medical Officer
• Dennis Reilly,
  Chief Financial Officer, Senior Vice President
• Dr. Kathryn MacFarlane Pharm.D.,
  Advisor
• Robert G. Conway M.E.,
  Sr. VP & Chief Supply Chain Officer
• Joseph D'Urso,
  Controller
• Dr. Paul Korner,
  Sr. VP & Chief Medical Officer
• Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.,
  Consultant
• Robert G. Conway,
  Sr. VP & Chief Supply Chain Officer
• Amy Welsh,
  VP of Marketing
• Matthew Riley,
  Head of Investor Relations & Corp. Communications
• Jason Butch,
  VP & Chief Accounting Officer
• Katie Mac Farlane,
  Chief Commercial Officer
• Scott M Coiante,
  Chief Financial Officer
• Karen Hong,
  Director
• Renee Selman,
  Chief Commercial Officer
• Jay Schreiber Alain Pro Que...,
  
• William Mckee,
  Director
• Abhijeet J Lele,
  Director
• Amy Welsh,
  Chief Commercial Officer
• Capital Iii Llc Care Capita...,
  
• Elizabeth Garner,
  Sr. VP & Chief Medical Officer
• Advisors Llcperceptive Life...,
  
• Ab Investor,
  10% owner
• Andrew N Schiff,
  Director
• Josephine Torrente,
  Director